Statistics for Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Total visits
| views | |
|---|---|
| Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody | 593 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 1 |
| February 2025 | 4 |
| March 2025 | 0 |
| April 2025 | 1 |
File Visits
| views | |
|---|---|
| Segal_2017_results.pdf | 667 |
| java.util.UUID:4896f61f-efbd-433c-a1ec-2870b1fa72d8 | 179 |
| java.util.UUID:459e1dce-5238-4aaa-9886-fd09b9fcb302 | 46 |
| java.util.UUID:d04cb50d-7c89-4fcb-95b3-5c9c039ed061 | 7 |
Top country views
| views | |
|---|---|
| United States | 278 |
| China | 114 |
| United Kingdom | 15 |
| Japan | 15 |
| South Korea | 12 |
| Germany | 11 |
| Italy | 10 |
| Australia | 8 |
| Canada | 8 |
| Sweden | 8 |
| Taiwan | 5 |
| Ukraine | 5 |
| Netherlands | 4 |
| Russia | 4 |
| France | 3 |
| Spain | 2 |
| India | 2 |
| Malaysia | 2 |
| Belgium | 1 |
| Brazil | 1 |
| Switzerland | 1 |
| Israel | 1 |
| Lebanon | 1 |
| Norway | 1 |
| Poland | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 55 |
| Beijing | 32 |
| Fairfield | 30 |
| Houston | 22 |
| Shanghai | 20 |
| Ann Arbor | 18 |
| Washington | 15 |
| Cambridge | 14 |
| Seoul | 10 |
| Kiez | 8 |
| Jacksonville | 7 |
| Stockholm | 7 |
| White Plains | 7 |
| Brisbane | 6 |
| Shenzhen | 6 |
| Florence | 5 |
| Kiev | 5 |
| Lake Mary | 5 |
| Southampton | 4 |
| Duncan | 3 |
| Foshan | 3 |
| Mount Laurel | 3 |
| Rockville | 3 |
| Saint Petersburg | 3 |
| Tacoma | 3 |
| Taipei | 3 |
| Taiyüan | 3 |
| Anaheim | 2 |
| Brooklyn | 2 |
| Burlington | 2 |
| Cixi | 2 |
| Kaohsiung City | 2 |
| Mississauga | 2 |
| Nanjing | 2 |
| Nanterre | 2 |
| New York | 2 |
| Norwalk | 2 |
| San Francisco | 2 |
| Storm Lake | 2 |
| Tokyo | 2 |
| Toronto | 2 |
| Turin | 2 |
| Vancouver | 2 |
| Wuhan | 2 |
| Alameda | 1 |
| Alexandria | 1 |
| Alicante | 1 |
| Beirut | 1 |
| Bengaluru | 1 |
| Cardiff | 1 |
| Chengdu | 1 |
| Clifton | 1 |
| Colonia | 1 |
| Derby | 1 |
| Detroit | 1 |
| Farmingville | 1 |
| Florianópolis | 1 |
| Fort Washington | 1 |
| Frankfurt am Main | 1 |
| Geneva | 1 |
| Guangzhou | 1 |
| Gunzenhausen | 1 |
| Gurgaon | 1 |
| Hangzhou | 1 |
| Harbin | 1 |
| Henryk | 1 |
| Hillsborough | 1 |
| Hürth | 1 |
| Indianapolis | 1 |
| Jerusalem | 1 |
| Kilburn | 1 |
| Kuala Lumpur | 1 |
| Leicester | 1 |
| Leiden | 1 |
| Lexington | 1 |
| Lincoln | 1 |
| Los Angeles | 1 |
| Louisville | 1 |
| Lowell | 1 |
| Mahwah | 1 |
| Milpitas | 1 |
| Minneapolis | 1 |
| Motala | 1 |
| Mountain View | 1 |
| Málaga | 1 |
| Naperville | 1 |
| Naples | 1 |
| New Haven | 1 |
| New Westminster | 1 |
| Newbury Park | 1 |
| Nijmegen | 1 |
| Niles | 1 |
| Oslo | 1 |
| Peterborough | 1 |
| Philadelphia | 1 |
| Raritan | 1 |
| Richmond | 1 |
| Rome | 1 |
| Rotterdam | 1 |
| Roubaix | 1 |